MR imaging as the primary modality for neuroradiologic evaluation of the lumbar spine. Effects on cost and number of examinations

Does choice of imaging modality affect outcome in dogs with thoracolumbar spinal conditions?

OBJECTIVES

A retrospective cross-sectional study was done to look for differences in outcome in canine spinal patients that had myelography compared to those that had magnetic resonance imaging.

METHODS

Medical records of dogs with spinal conditions in the period January 2004 to December 2007 were reviewed. Data on patient age, gender, breed, size, neurolocalisation, rate of onset, imaging modality, time taken to image, type of treatment, neurological grade at admission and discharge, length and cost of hospitalisation and status at discharge were collected. Only dogs with neurological grade 3 to 6 with signs referable to the thoracolumbar spine were included.

RESULTS

Of 107 dogs that met the inclusion criteria, 66 (62%) had myelography and 41 (38%) had magnetic resonance imaging. Using multivariable analyses, non-chondrodystrophoid breed, increasing age and higher neurological grade at admission were found to be associated negatively with survival. Neurological grade 5 at admission was found to be associated positively with likelihood of neurological improvement. Male gender, higher neurological grade at admission and medical treatment were associated negatively with length of hospitalisation. magnetic resonance imaging, surgical treatment and period of hospitalisation were associated positively with total cost of hospitalisation.

CLINICAL SIGNIFICANCE

No significant association was found between type of imaging and any patient outcome variables except cost of hospitalisation, which was higher for dogs having magnetic resonance imaging. Although magnetic resonance imaging may be considered advantageous compared to myelography because it is non-invasive and provides superior anatomical detail for surgical guidance, no beneficial effect on outcome of dogs with non-ambulatory thoracolumbar spinal disease was found.

Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases

BACKGROUND

There is currently no technique to image quantitatively bone metastases. Here, we assessed the value of MRI of the axial skeleton (AS-MRI) as a single step technique to quantify bone metastases and measure tumor response.

METHODS

AS-MRI was performed in 38 patients before receiving chemotherapy for metastatic HRPCa, in addition to PSA, computed tomography of the thorax, abdomen, and pelvis [CT-TAP]; and Tc-99m bone scintigraphy. A second AS-MRI was performed in 20 patients who completed 6 months of chemotherapy. Evaluation of tumor response was performed using RECIST.

RESULTS

Only 11 patients (29%) had RECIST measurable metastases in soft-tissues or lymph nodes on baseline CT-TAP. AS-MRI identified a diffuse infiltration of the bone marrow in 8 patients and focal measurable metastatic lesions in 25 patients (65%), therefore, doubling the proportion of patients with measurable lesions. Transposing RECIST on AS-MRI in 20 patients who completed 6 months of treatment, allows the accurate estimation of complete response (n = 2), partial response (n = 2), stable disease (n = 5), or tumor progression (n = 11), as it is done using CT-TAP in soft tissue solid metastases.

CONCLUSIONS

MRI of axial skeleton enables precise measurement and follow-up of bone metastases as it is for other soft-tissue metastasis.